Provided by Tiger Trade Technology Pte. Ltd.

First Advantage Corp.

20.44
-0.1100-0.54%
Volume:826.51K
Turnover:17.00M
Market Cap:3.51B
PE:140.75
High:20.88
Open:20.81
Low:20.38
Close:20.55
52wk High:25.15
52wk Low:8.82
Shares:171.54M
Float Shares:93.74M
Volume Ratio:0.63
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1452
EPS(LYR):-0.2011
ROE:1.94%
ROA:2.82%
PB:2.71
PE(LYR):-101.66

Loading ...

Lexeo Advances Pivotal LX2006 Trial for FA Cardiomyopathy

TIPRANKS
·
Jun 15

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

GlobeNewswire
·
Jun 15

First Advantage rises 7.3%

TIPRANKS
·
Jun 12

Shares of First Advantage Climb on Inclusion in S&P SmallCap 600 Index

Deep News
·
Jun 12

BUZZ-First Advantage jumps on S&P SmallCap addition

Reuters
·
Jun 12

First Advantage to replace Kennedy Wilson in S&P 600 at open on 6/16

TIPRANKS
·
Jun 12

S&P Dow Jones Indices Says First Advantage Corporation Will Replace Kennedy-Wilson Holdings Inc. in the S&P Smallcap 600

THOMSON REUTERS
·
Jun 12

First Advantage director Clark James Lindsey reports sale of 4,921 common shares for $77,195.49

Reuters
·
Jun 11

First Advantage Shareholders Endorse Board, Pay and Auditor

TIPRANKS
·
Jun 09

First Advantage holds annual shareholder meeting

Reuters
·
Jun 09

First Advantage Chief Legal Officer Bret T. Jardine disposes of 25,000 common shares for $417,640

Reuters
·
Jun 04

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 02

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Jun 01

First Advantage publishes investor presentation outlining AI-driven screening, digital identity strategy

Reuters
·
May 30

Assessing First Advantage (FA) Valuation After A Strong Short Term Share Price Rebound

Simply Wall St.
·
May 30

X-FAB Shares Surge 77% Following AI Chip Analyst's Bullish Endorsement, Sparking Retail Investor Frenzy

Deep News
·
May 28

Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

GlobeNewswire
·
May 19

Design Therapeutics announces biomarker, clinical data from RESTORE-FA trial

TIPRANKS
·
May 18

Exploring US High Growth Tech Stocks This May 2026

Simply Wall St.
·
May 15

Myles Minter Reiterates Buy on Larimar as Nomlabofusp Advances Toward 2026 BLA and Potential First Disease‑Modifying FA Therapy by 2027

TIPRANKS
·
May 15